Marco Schiuma Selected Research

Marco Schiuma Research Topics

5	COVID-19 11/2023 - 10/2020
4	Infections 07/2023 - 12/2020
2	Respiratory Insufficiency (Respiratory Failure) 11/2023 - 01/2021
1	Pulmonary Aspergillosis 01/2024
1	Delirium 11/2023
1	Sepsis (Septicemia) 11/2023
1	Thrombosis (Thrombus) 11/2023
1	Hemorrhage 11/2023
1	Pneumothorax 01/2021
1	Inflammation (Inflammations) 01/2021
1	Mediastinal Emphysema (Pneumomediastinum) 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Cardiotoxicity 12/2020
1	Obesity 01/2020

1	mRNA VaccinesIBA 01/2021
1	BNT162 VaccineIBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	AntigensIBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	Immunoglobulin IsotypesIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	VaccinesIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 12/2020
1	Lopinavir FDA Link 12/2020
1	Ritonavir (Norvir)FDA Link 12/2020
1	Retinaldehyde (Retinal)IBA 10/2020
1	CreatinineIBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	C-Reactive ProteinIBA 01/2020

3	Polypharmacy 01/2024 - 12/2020
2	Continuous Positive Airway Pressure 11/2023 - 01/2021
1	Therapeutics 01/2024
1	Palliative Care (Palliative Therapy) 11/2023
1	Catheters 11/2023
1	Punctures 11/2023
1	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 01/2021
1	Noninvasive Ventilation 01/2021